SNDA
Sonida Senior Living, Inc.
SNDA lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
SNDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Weak |
SNDA's revenue is currently strong, but its profitability, cash flow and balance sheet are weak.
SNDA PE Valuation
SNDA has no meaningful PE right now: it lost money over the past year.
SNDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SNDA's losses to shrink, with revenue growing.
SNDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.36 | -$2.01 |
| Q2 2026 | -$6.20 | -$3.43 |
| Q1 2026 | -$5.84 | -$2.37 |
| Q4 2025 | -$4.22 | -$3.68 |
| Q3 2025 | -$3.35 | -$1.96 |
| Q2 2025 | -$2.77 | +$0.43 |
| Q1 2025 | -$3.47 | +$0.98 |
| Q4 2024 | -$0.54 | +$3.31 |
SNDA is still losing money, but far less than before: $5.36 per share over the past year, against $134.88 at its worst in late 2020.
SNDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $210.2M | +114% |
| Q2 2026 | $207.6M | +122% |
| Q1 2026 | $122.6M | +33% |
| Q4 2025 | $97.7M | +6.2% |
| Q3 2025 | $98M | +31% |
| Q2 2025 | $93.5M | +33% |
| Q1 2025 | $91.9M | +36% |
| Q4 2024 | $91.9M | +40% |
SNDA's revenue has grown year over year for 18 quarters in a row: $210M last quarter, up 114% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.3% | +6.5 points |
| Q2 2026 | -2.6% | -0.2 points |
| Q1 2026 | -24% | -46 points |
| Q4 2025 | -22% | -15 points |
| Q3 2025 | -16% | -9.2 points |
| Q2 2025 | -2.4% | -0.4 points |
| Q1 2025 | 22% | +25 points |
| Q4 2024 | -7% | -0.1 points |
SNDA's operating margin was −9.3% last quarter, up 6.5 points from the same quarter a year ago.
SNDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.6M | +360% |
| Q2 2026 | -$3.7M | -292% |
| Q1 2026 | -$42.6M | -$38.1M |
| Q4 2025 | -$9.3M | +$1.1M |
| Q3 2025 | $3M | +$8M |
| Q2 2025 | $1.9M | +$3.6M |
| Q1 2025 | -$4.5M | +$5.4M |
| Q4 2024 | -$10.4M | -$6.6M |
SNDA has burned cash in most quarters: −$42M over the past year, against −$10M the year before.
SNDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 32.9x | High |
| Q2 2026 | 72.2x | High |
| Q4 2025 | 18.1x | High |
| Q3 2025 | 13.0x | High |
| Q2 2025 | 11.5x | High |
| Q1 2025 | 11.5x | High |
| Q4 2024 | 21.7x | High |
| Q3 2024 | 20.8x | High |
SNDA's net debt is more than 20 years of its operating earnings (EBITDA), up from 11 years a year ago.
SNDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.7 | Oversold |
SNDA's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
SNDA PE vs Healthcare Sector
| Metric | SNDA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SNDA has no meaningful PE right now: it lost money over the past year.
SNDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.0 | 5.3% below |
| 20 week MA | $37.9 | 12% below |
| 50 week MA | $35.7 | 7% below |
| 100 week MA | $30.4 | 9.1% above |
| 200 week MA | $23.7 | 40% above |
SNDA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 40% above its 200-week average.
SNDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.6 | $12.9 | -73% |
| 2021 | $12.9 | $28.6 | +122% |
| 2022 | $28.6 | $11.7 | -59% |
| 2023 | $11.7 | $9.66 | -17% |
| 2024 | $9.66 | $22.9 | +137% |
| 2025 | $22.9 | $32.3 | +41% |
| 2026 YTD | $32.3 | $33.2 | +2.8% |
SNDA's yearly returns have swung widely, from +137% in 2024 to −73% in 2020. It's up 2.8% so far in 2026.